Navigation Links
Kosan Announces Data Presentations at Upcoming AACR Annual Meeting

.com.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 (the "Act"). Such forward-looking statements include but are not limited to statements regarding anticipated presentations of data relating to Kosan's product candidates. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. There are a number of important factors that could cause the results of Kosan to differ materially from those indicated by these forward- looking statements, including, among others, the risks detailed from time to time in the Company's SEC reports, including its Annual Report on Form 10-K for the year ended December 31, 2006 and other periodic filings with the SEC. Kosan does not undertake any obligation to update forward-looking statements.

NOTE: Velcade(R) (bortezomib) is a registered trademark of Millennium Pharmaceuticals, Inc.

Herceptin(R) (trastuzumab) is a registered trademark of Genentech, Inc.

CONTACT: Jane Green, VP, Corporate Communications of Kosan BiosciencesIncorporated, +1-510-731-5335, or mobile, +1-415-652-4819, or green@kosan.com

Web site: http://www.kosan.com/

Ticker Symbol: (NASDAQ-NMS:KOSN)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
6. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
7. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
8. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
9. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
11. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
Post Your Comments:
(Date:7/31/2015)... 31, 2015  Semler Scientific, Inc. (Nasdaq: SMLR ... to healthcare insurers and physician groups, today reported financial ... "In the second quarter of 2015, ... growth of 54%, quarter over quarter revenue growth of ... base of FloChec® units of 18%," said Doug Murphy-Chutorian, ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/31/2015)...  Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage ... of autoimmune diseases, asthma and allergic diseases, and cancer, ... to its board of directors. ... is a tremendous asset to our board," said ... of Xencor. "Xencor faces a range of opportunities for ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... SCOTTSDALE, Ariz., Oct. 19 Matrixx Initiatives, Inc. (Nasdaq: ... financial results for the fiscal 2011 second quarter and six ... market closes on Monday, October 25, 2010. An earnings conference ... 26, 2010 at 11:00 AM ET. To access ...
... Reportlinker.com announces that a new market research ... Global Top 10 Health Care Equipment ... http://www.reportlinker.com/p0315869/Global-Top-10-Health-Care-Equipment-Companies---Industry-Financial-and-SWOT-Analysis.html ... Financial and SWOT Analysis Datamonitor,s Global ...
Cached Medicine Technology:Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 Second Quarter Financial Results 2Reportlinker Adds Global Top 10 Health Care Equipment Companies - Industry, Financial and SWOT Analysis 2Reportlinker Adds Global Top 10 Health Care Equipment Companies - Industry, Financial and SWOT Analysis 3Reportlinker Adds Global Top 10 Health Care Equipment Companies - Industry, Financial and SWOT Analysis 4
(Date:7/31/2015)... ... July 31, 2015 , ... ... " from NBC talked about a woman’s unfortunate experience having cosmetic skin procedures ... her face, which resulted in blistering, swelling, bruising, and pain. This woman’s experience ...
(Date:7/31/2015)... Georgia (PRWEB) , ... July 31, 2015 , ... Easter Seals Southern Georgia’s Heels & ... near Waycross, Georgia. Start time will be 7:30 AM. The duathlon is a 2 mile ... mile swim in Laura Walker Lake, a 13 mile bike, and a 3 mile run. ...
(Date:7/31/2015)... NJ (PRWEB) , ... July 31, 2015 , ... ... sleep apnea (OSA) and the growing number of individuals who remain undiagnosed, treatment ... Americans continue to shy away from traditional CPAP therapy due to its overall ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... On July ... meeting in Manatee county to discuss plausible solutions for controlling the heroin outbreak. Ultimately ... event of an overdose is largely perpetuating the heroin crisis in North Florida. The ...
(Date:7/30/2015)... ... ... OSF Healthcare System has been recognized as one of the ... Hospitals & Health Networks. This marks the fourth consecutive year for this achievement by ... the Third Order of St. Francis . , Health data security and patient engagement ...
Breaking Medicine News(10 mins):Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3Health News:Heels & Wheels for Megan's House Set for Saturday August 22, 2015 in Waycross, Georgia 2Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 3Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
... updated clinical,practice guideline released today by the U.S. ... treatments that are effective for,helping people quit smoking. ... includes,a commentary that urges clinicians to use the ... of tobacco., Treating Tobacco Use and Dependence: ...
... commitment,to improve services to those seriously injured in ... and its federal partners have marked a,milestone with ... of,workers to key military treatment facilities., "The ... his,advisory commission on war veterans, needs, and today ...
... dementia, according to researchers at the Johns Hopkins Bloomberg ... obesity and dementia prospective follow-up studies over the past ... diseases. The results are published by The International Association ... issue of Obesity Reviews. , Our analysis of the ...
... ABT ),will present at the Citi Investment Research ... C. Freyman, executive vice president,finance and chief financial officer, ... Central time., A live audio webcast of the ... at http://www.abbottinvestor.com . An,archived edition of the presentation ...
... R.I. By linking HIV positive prisoners to ... innovative program called Project Bridge, 95 percent of ... year after being released from incarceration, according to ... care can reduce costs to the criminal justice ...
... its way across the Bay of Bengal just south of ... region and ripped through the heart of Myanmar on Saturday, ... Office for the Coordination of Humanitarian Affairs (OCHA) asked the ... initiative, referred to as The Charter, was founded in October ...
Cached Medicine News:Health News:New Evidence Provides Clinicians With Better Tools to Help Smokers Quit 2Health News:New Evidence Provides Clinicians With Better Tools to Help Smokers Quit 3Health News:VA-DoD Program Serves Severely Disabled Combat Veterans 2Health News:Obesity linked to increased risk for dementia 2Health News:Prisoner HIV program leads to continuum of medical care after release 2Health News:Prisoner HIV program leads to continuum of medical care after release 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: